Stocks · Korea 304360 KOSDAQ

S.Biomedics

23,450원 +0.64% Market cap 2,927억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR33.03x
EPS0 KRW
BPS710 KRW
ROE0.00%
DPS0 KRW

Returns and 52-week range

1W+11.11%
1M+23.13%
3M+10.84%
6M-16.06%
1Y-7.63%
YTD-37.92%
52W high42,600원
52W low13,910원
From 52W high-46.01%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2023131억-60억0원-45.7%
2024137억-54억-58억-39.6%
2025165억-83억0원-50.4%
Quarterly
2024 4Q44억-11억-44억-24.9%
2025 1Q45억-17억0원-37.9%
2025 2Q48억-20억0원-42.6%
2025 3Q32억-19억0원-59.4%
2025 4Q40억-27억0원-66.4%
2026 1Q44억-30억0원-68.0%

Company

CEO강세일
Founded2003-08-11
Fiscal year end12
Address: 경기도 파주시 문발로 320 사무동, 연구동

Peers in the same sector

CompanyMarket capP/EP/B1M
일성아이에스2,953억130.590.41+7.51%
휴메딕스2,914억5.170.96+2.78%
휴온스글로벌3,032억10.120.53+1.27%
유나이티드제약2,859억6.870.63-2.71%
유바이오로직스3,120억7.531.78-1.04%
지놈앤컴퍼니2,782억—2.21+58.81%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.